Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.

Authors

Bernard Zinman
Silvio E Inzucchi
John M Lachin, George Washington UniversityFollow
Christoph Wanner
David Fitchett
Sven Kohler
Michaela Mattheus
Hans J Woerle
Uli C Broedl
Odd Erik Johansen
Gregory W Albers
Hans Christoph Diener

Document Type

Journal Article

Publication Date

4-6-2017

Journal

Stroke; A Journal of Cerebral Circulation

DOI

10.1161/STROKEAHA.116.015756

APA Citation

Zinman, B., Inzucchi, S., Lachin, J., Wanner, C., Fitchett, D., Kohler, S., Mattheus, M., Woerle, H., Broedl, U., Johansen, O., Albers, G., & Diener, H. (2017). Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.. Stroke; A Journal of Cerebral Circulation, (). http://dx.doi.org/10.1161/STROKEAHA.116.015756

Peer Reviewed

1